Brigitte Dupriez

7.0k total citations · 1 hit paper
62 papers, 4.1k citations indexed

About

Brigitte Dupriez is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Brigitte Dupriez has authored 62 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 34 papers in Hematology and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Brigitte Dupriez's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers), Acute Myeloid Leukemia Research (20 papers) and Lymphoma Diagnosis and Treatment (20 papers). Brigitte Dupriez is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (28 papers), Acute Myeloid Leukemia Research (20 papers) and Lymphoma Diagnosis and Treatment (20 papers). Brigitte Dupriez collaborates with scholars based in France, Italy and United Kingdom. Brigitte Dupriez's co-authors include F Bauters, Pierre Morel, JL Demory, JL Laï, Francisco Cervantes, Isabelle Plantier, Giovanni Barosi, Michèle Simon, Alessandro M. Vannucchi and John T. Reilly and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Brigitte Dupriez

62 papers receiving 4.0k citations

Hit Papers

New prognostic scoring system for primary myelofibrosis b... 2008 2026 2014 2020 2008 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigitte Dupriez France 30 3.2k 2.6k 1.4k 1.1k 850 62 4.1k
Emanuela Boveri Italy 37 2.9k 0.9× 2.0k 0.7× 1.5k 1.1× 850 0.8× 1.3k 1.5× 99 4.3k
Ryan A. Knudson United States 28 2.0k 0.6× 2.3k 0.9× 1.4k 1.0× 535 0.5× 537 0.6× 89 3.4k
Rebecca F. McClure United States 31 2.9k 0.9× 2.4k 0.9× 2.0k 1.4× 1.4k 1.3× 599 0.7× 64 4.5k
Isabelle Plantier France 12 1.1k 0.4× 843 0.3× 480 0.3× 306 0.3× 1.1k 1.2× 22 2.2k
Alfonso Zaccaria Italy 24 871 0.3× 1.2k 0.4× 385 0.3× 249 0.2× 653 0.8× 116 2.1k
Richard Garand France 32 1.5k 0.5× 1.5k 0.6× 957 0.7× 140 0.1× 1.1k 1.3× 80 3.2k
Elisa Rumi Italy 42 6.9k 2.2× 5.1k 1.9× 4.3k 3.1× 2.8k 2.6× 203 0.2× 132 7.6k
Umberto Magrini Italy 26 885 0.3× 758 0.3× 368 0.3× 296 0.3× 882 1.0× 95 2.3k
Christopher Pocock United Kingdom 23 1.1k 0.4× 810 0.3× 166 0.1× 386 0.4× 1.2k 1.5× 64 2.1k
Lourdes Florensa Spain 23 1.1k 0.4× 1.0k 0.4× 596 0.4× 149 0.1× 571 0.7× 120 2.0k

Countries citing papers authored by Brigitte Dupriez

Since Specialization
Citations

This map shows the geographic impact of Brigitte Dupriez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Dupriez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Dupriez more than expected).

Fields of papers citing papers by Brigitte Dupriez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Dupriez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Dupriez. The network helps show where Brigitte Dupriez may publish in the future.

Co-authorship network of co-authors of Brigitte Dupriez

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Dupriez. A scholar is included among the top collaborators of Brigitte Dupriez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Dupriez. Brigitte Dupriez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desterke, Christophe, Christophe Martinaud, Bernadette Guerton, et al.. (2015). Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis. Haematologica. 100(6). 757–767. 6 indexed citations
2.
Martinaud, Christophe, Christophe Desterke, Johanna Konopacki, et al.. (2015). Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis. Genomics Data. 5. 1–2. 4 indexed citations
5.
Andrieux, Joris, Sandrine Geffroy, Chrystèle Bilhou‐Nabera, et al.. (2005). Cryptic 6p21.3 duplications and triplication involving HMGA1 partially masked by add 6p in four cases of myelodysplasia. Cancer Genetics and Cytogenetics. 164(1). 84–87. 8 indexed citations
6.
Diviné, Marine, Philippe Casassus, Serge Koscielny, et al.. (2005). Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Annals of Oncology. 16(12). 1928–1935. 82 indexed citations
7.
Andrieux, Joris, Jean‐Loup Demory, Brigitte Dupriez, et al.. (2003). Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes and Cancer. 39(1). 82–87. 39 indexed citations
8.
Dupriez, Brigitte & Jean‐Loup Demory. (2002). La splénomégalie myéloïdeMise à jour des critères diagnostiques, des facteurs pronostiques et du traitement. Hématologie. 8(3). 197–203. 1 indexed citations
9.
Rosé, Christian, et al.. (2001). Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases. Leukemia. 15(6). 950–953. 31 indexed citations
10.
Dupriez, Brigitte, Marc A. Simon, Laurence Detourmignies, et al.. (1999). The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases. Leukemia. 13(2). 282–288. 8 indexed citations
11.
Bosly, André, Éric Lepage, Bertrand Coiffier, et al.. (1996). Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study. British Journal of Haematology. 93. 546–546. 2 indexed citations
12.
Castaigné, Sylvie, E Archimbaud, Pierre Fenaux, et al.. (1994). Place de la double induction dans le traitement des leucémies aiguës myéloblastiques de l'adulte : résultats intermédiaires du protocole LAM90. 36. 2 indexed citations
13.
Bosly, André, Éric Lepage, Bertrand Coiffier, et al.. (1993). Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study. Blood. 82(10). 2 indexed citations
14.
Morel, Pierre, et al.. (1993). Long-term outcome of follicular low-grade lymphoma a report of 91 patients. Annals of Hematology. 66(6). 303–308. 19 indexed citations
15.
Morel, Pierre, I. Quiquandon, Anne Janin, et al.. (1993). High incidence of lymphoid infiltration on labial salivary gland biopsy in non‐Hodgkin's lymphomas: clinical implications. British Journal of Haematology. 85(1). 93–98. 8 indexed citations
16.
Morel, Pierre, Brigitte Dupriez, Bernard Gosselin, et al.. (1993). Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). A study of 59 cases. Cancer. 71(1). 207–215. 40 indexed citations
17.
Dupriez, Brigitte, et al.. (1991). VIM3‐ARA C: An effective salvage regimen in refractory or recurrent aggressive non hodgkin's lymphoma. A report on 18 cases. Hematological Oncology. 9(4-5). 259–266. 2 indexed citations
18.
Fenaux, P, et al.. (1990). [Primary cardiac lymphoma. A new case].. PubMed. 141(5). 485–7. 3 indexed citations
19.
Lepelley, Pascale, et al.. (1990). Congenital diserythropoietic anemia type I. Annals of Hematology. 61(4). 248–250. 6 indexed citations
20.
Zandecki, Marc, Brigitte Dupriez, JL Laï, et al.. (1987). [Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].. PubMed. 29(6). 365–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026